Literature DB >> 30826864

Diverse cutaneous manifestation of Langerhans cell histiocytosis: a 10-year retrospective cohort study.

Supattarawadee Poompuen1, Jitjira Chaiyarit2, Leelawadee Techasatian3.   

Abstract

Cutaneous manifestation is a common presentation of LCH and is usually a leading clue for the disease diagnosis. Having cutaneous lesions did not show a significantly early age onset at diagnosis compared to those without skin lesions, P value = 0.71. In the present study, cutaneous findings were found as 77.7%. Seborrheic dermatitis-like lesions were the most common cutaneous type (42.8%), followed by papules/nodules/masses (28.5%), petechiae/hemorrhagic lesions (17.8%), and eczematous lesions (10.7%). Time to diagnosis of LCH presented with seborrheic dermatitis-like lesions was significantly longer than other cutaneous presentations, P value = 0.0011.
Conclusion: Patients with LCH who had the manifestations of seborrheic dermatitis-like lesions can have diagnosis delayed due to the difficulty in distinguishing these lesions from normal seborrheic dermatitis lesions. Petechiae/hemorrhagic cutaneous signs in addition to the normal seborrheic dermatitis is the clue for early detection of the disease. To improve early detection of LCH, general pediatricians should be alerted to be aware of these skin symptoms, and if they persist, a dermatologist, pediatric if available, should be immediately consulted. What is Known? • Cutaneous manifestation is a common presentation of LCH and is usually a leading clue for the disease diagnosis. What is New? • Patients with LCH who have the manifestations of seborrheic dermatitis-like lesions can have a delayed diagnosis due to the difficulty in distinguishing normal from seborrheic dermatitis lesions. • Petechiae/hemorrhagic cutaneous signs in addition to the normal seborrheic dermatitis are the clue to the early disease detection.

Entities:  

Keywords:  Hemorrhagic lesions; LCH; Langerhans cell histiocytosis; Petechiae; Seborrheic dermatitis

Mesh:

Year:  2019        PMID: 30826864     DOI: 10.1007/s00431-019-03356-1

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  6 in total

Review 1.  [Histiocytosis in the dermatological context of the new classification].

Authors:  C Lang; J-T Maul; L Krähenbühl; F Dimitriou; R Dummer
Journal:  Hautarzt       Date:  2019-09       Impact factor: 0.751

Review 2.  Childhood Langerhans cell histiocytosis: a disease with many faces.

Authors:  Alexander K C Leung; Joseph M Lam; Kin Fon Leong
Journal:  World J Pediatr       Date:  2019-08-28       Impact factor: 2.764

Review 3.  Langerhans cell histiocytosis: Case report and literature review

Authors:  Miguel Ángel Medina; Wendy Meyer; Carolina Echeverri; Natalia Builes
Journal:  Biomedica       Date:  2021-09-22       Impact factor: 0.935

4.  A Newborn Female with a Diffuse Rash.

Authors:  Zachary E Holcomb; Sherry H Yu; Tyler D Menge; Rosalynn M Nazarian; Chad J Jessup
Journal:  Dermatopathology (Basel)       Date:  2019-09-04

5.  Skin-limited Langerhans cell histiocytosis presenting as crusted papules in an acneiform distribution in an adolescent man.

Authors:  Rachel Choi; Christine J Ko; Anna Eisenstein
Journal:  JAAD Case Rep       Date:  2021-12-15

6.  18F-FDG PET/MR Assessment of Pediatric Langerhans Cell Histiocytosis.

Authors:  Jialing Niu; Jiangtao Liang; Qi Feng; Mei Wang; Luoyu Wang; Xiuhong Ge; Xiao Wang; Zhongxiang Ding
Journal:  Int J Gen Med       Date:  2021-10-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.